BioArctic Competitors and Similar CompaniesClear all

BioArctic's competitors and similar companies include Roche, Abnova Corporation, Genfit and Esperite.

	BioArctic BioArctic is a research-based biopharmaceutical company mainly focused on disease-modifying treatments and diagnostics for neurodegenerative diseases.	Roche Roche Holding is a biotech company that provides in vitro diagnostics and supplies services.	Abnova Corporation Abnova is a biotech company specializing in antibody and protein production.	Genfit GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs.	Esperite Esperite is a company specializing in regenerative and predictive medicine.
Founding Date	Founding Date 2003	Founding Date 1896	Founding Date 2002	Founding Date 1999	Founding Date 2000
Type	Type Public	Type Public	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech drug development medical diagnostics pharma	Tags Healthcare biotech drug development medical diagnostics pharma	Tags Healthcare biotech drug development medical diagnostics pharma	Tags Healthcare biotech drug development medical diagnostics pharma	Tags Healthcare biotech drug development medical diagnostics pharma
Locations	Locations Stockholm , SE HQ	Locations Basel, CH HQ Hydra, DZ Ricardo Rojas, AR North Ryde, AU Sydney, AU Wien, AT Dhaka, BD see more	Locations TW HQ Walnut, US	Locations Loos, FR HQ Cambridge, US	Locations Amsterdam, NL HQ Villeurbanne, FR
Employees	Employees 107	Employees 103,249	Employees 522% decrease	Employees 180	Employees 133
Valuation ($)	Valuation ($) 1.3 b	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 280.8 m	Valuation ($) 38.3 m
Financial
Revenue (est.)	Revenue (est.) kr2b (FY, 2025)	Revenue (est.) CHF61.5b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) €65.4m (FY, 2025)	Revenue (est.) €11.8m (FY, 2018)
Cost of goods	Cost of goods kr59.2m (FY, 2025)	Cost of goods CHF13.1b (FY, 2025)	Cost of goods N/A	Cost of goods €302k (FY, 2025)	Cost of goods €4.3m (FY, 2018)
Gross profit	Gross profit kr1.9b (FY, 2025)	Gross profit CHF50.5b (FY, 2025)	Gross profit N/A	Gross profit €70.8m (FY, 2025)	Gross profit €7.5m (FY, 2018)
Net income	Net income kr1b (FY, 2025)	Net income CHF13.8b (FY, 2025)	Net income N/A	Net income (€86m) (FY, 2025)	Net income (€18.5m) (FY, 2018)